Researchers sought to determine whether varicella-zoster virus vaccination with a recombinant vaccine would show results in patients who underwent HSCT.
The expanded approval was based on pediatric extrapolation of efficacy from adequate and well-controlled studies and pharmacokinetic data in adult heart transplant and liver transplant patients.
Among orthotopic heart transplant (OHT) recipients, COVID-19 vaccination is associated with fewer COVID-19 infections, hospitalizations, and deaths and no heart transplant-specific adverse events.
Adolescent and young adult (AYA) solid organ transplant recipients should be supported after transfer to adult health care, with improved clinical outcomes in association with successful retention in adult health care.
A study was conducted to determine the relationship between donor-transmitted lipid burden and plaque progression 12 months following heart transplant.
A new allocation system for heart transplant candidates was analyzed to determine its effect on waitlist time and delisting for patients with type O blood.
A study was conducted to determine the rate of hemolysis potential acquired van Willebrand syndrome in patients who have received a total artificial heart implantation.